Error loading player: No playable sources found
Session III: Biological Consequences of HOS
Date
April 13, 2021
This product is not available for individual purchase, but it is available as part of the following products:
Session Chair
Takeda Pharmaceutical Company Limited
Session Speakers
GlaxoSmithKline
Bristol-Myers Squibb Company
Eli Lilly and Company
Related Products
Uncover Structure-Activity Relationships and Reduce Development Risks with HDX-MS - Technical Seminar Sponsored by Waters Corporation
Small changes in structure can lead to loss of activity and/or an increase in aggregation. Structure-activity relationships are not isolated to the epitope either – both proximal and distal changes can have deleterious impacts on a biologics’ function…
Characterizing Protein Aggregates and Higher Order Structures using AUC - Technical Seminar Sponsored by Beckman Coulter Life Sciences
In the half century since the first crystallography derived structure of a protein; structural biology has blossomed into a mature discipline exploring the correlation between structure, dynamics and function of proteins…
